134 related articles for article (PubMed ID: 1283241)
1. [T-cell rich B-cell lymphoma associated with hemophagocytic syndrome].
Dommann-Scherrer C; Zimmermann D; Hassam S; Odermatt BF; Risti B; Maurer R
Verh Dtsch Ges Pathol; 1992; 76():122-5. PubMed ID: 1283241
[TBL] [Abstract][Full Text] [Related]
2. [Nasal NK cell lymphoma with hemophagocytic syndrome developed tumor lysis syndrome after CHOP therapy].
Sawada M; Yamada T; Tsurumi H; Moriwaki H
Rinsho Ketsueki; 2002 Nov; 43(11):988-92. PubMed ID: 12508484
[TBL] [Abstract][Full Text] [Related]
3. Anaphylactoid reaction to cyclophosphamide in a patient with T cell lymphoma and hemophagocytic syndrome.
Minami R; Hirase N; Motomura S; Muta K; Nawata H; Nishimura J
Int J Hematol; 1999 Jan; 69(1):57-8. PubMed ID: 10641445
[No Abstract] [Full Text] [Related]
4. The additive effect of peripheral blood stem cells, harvested with low-dose cyclophosphamide, to autologous bone marrow reinfusion on hematopoietic reconstitution after ablative chemotherapy in breast cancer patients with localized disease.
de Graaf H; Mulder NH; Willemse PH; van der Graaf WT; Sleijfer DT; Zijlstra JG; Elias M; Sibinga CT; Vellenga E; de Vries EG
Anticancer Res; 1995; 15(6B):2851-6. PubMed ID: 8669878
[TBL] [Abstract][Full Text] [Related]
5. Granulocyte colony-stimulating factor (G-CSF) prevents dose-limiting neutropenia in lymphoma patients receiving standard dose chemotherapy.
Dotti G; Stella CC; Mangoni L; Cottafavi L; Caramatti C; Almici C; Rizzoli V
Haematologica; 1995; 80(2):142-5. PubMed ID: 7543069
[TBL] [Abstract][Full Text] [Related]
6. Role of chemotherapy and GM-CSF on hemopoietic progenitor cell mobilization in multiple myeloma.
Tarella C; Boccadoro M; Omedé P; Bondesan P; Caracciolo D; Frieri R; Bregni M; Siena S; Gianni AM; Pileri A
Bone Marrow Transplant; 1993 Apr; 11(4):271-7. PubMed ID: 7683551
[TBL] [Abstract][Full Text] [Related]
7. Hepatosplenic gamma/delta T-cell lymphoma in bone marrow. A sinusoidal neoplasm with blastic cytologic features.
Vega F; Medeiros LJ; Bueso-Ramos C; Jones D; Lai R; Luthra R; Abruzzo LV
Am J Clin Pathol; 2001 Sep; 116(3):410-9. PubMed ID: 11554170
[TBL] [Abstract][Full Text] [Related]
8. T-cell-rich B-cell lymphoma of the spleen presenting with severe hypersplenism.
Dincol G; Agan M; Dogan O; Diz-Kucukkaya R; Uslu B
Clin Lab Haematol; 2006 Dec; 28(6):419-22. PubMed ID: 17105497
[TBL] [Abstract][Full Text] [Related]
9. Treatment of a delayed graft failure after allogeneic bone marrow transplantation with IL-3 and GM-CSF.
Vannucchi AM; Bosi A; Laszlo D; Guidi S; Saccardi R; Rossi-Ferrini P
Haematologica; 1995; 80(4):341-3. PubMed ID: 7590505
[TBL] [Abstract][Full Text] [Related]
10. [Microcellular lung carcinoma in patient with hepatosplenic T-cell lymphoma: a case report].
Kalac M; Ostojić S; Gasparov S; Planinc-Peraica A; Dominis M; Jaksić B
Lijec Vjesn; 2006; 128(3-4):76-8. PubMed ID: 16808095
[TBL] [Abstract][Full Text] [Related]
11. Post-transplant hepatosplenic T-cell lymphoma successfully treated with HyperCVAD regimen.
Tey SK; Marlton PV; Hawley CM; Norris D; Gill DS
Am J Hematol; 2008 Apr; 83(4):330-3. PubMed ID: 17876769
[TBL] [Abstract][Full Text] [Related]
12. ProMACE-CytaBOM: combination chemotherapy for diffuse large cell lymphoma.
Prokocimer M; Modan M; Rusoshansky S; Bairey O; Shaklai M
Anticancer Res; 1989; 9(4):1233-5. PubMed ID: 2479327
[TBL] [Abstract][Full Text] [Related]
13. [Angioimmunoblastic T-cell lymphoma associated with hemophagocytic syndrome at onset and relapse].
Takai K; Sanada M
Rinsho Ketsueki; 2000 Dec; 41(12):1260-6. PubMed ID: 11201151
[TBL] [Abstract][Full Text] [Related]
14. Hemophagocytic syndrome in ileum-origin B-cell lymphoma.
Motegi S; Nishizaki Y; Muramatsu C; Nakamura H; Kobayashi F; Shiozawa H; Kamochi J; Itakura M; Shibuya M; Ogawa T; Matsuzaki S
J Gastroenterol; 2003; 38(10):995-9. PubMed ID: 14614609
[TBL] [Abstract][Full Text] [Related]
15. Rare variety of T-cell lymphoma.
Pednekar S; Morge V; Rawal S; Korivi D; Ramteke V; Naik K
J Assoc Physicians India; 2011 Oct; 59():667-8. PubMed ID: 22479752
[TBL] [Abstract][Full Text] [Related]
16. 14-day variant of the bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone regimen in advanced-stage Hodgkin's lymphoma: results of a pilot study of the German Hodgkin's Lymphoma Study Group.
Sieber M; Bredenfeld H; Josting A; Reineke T; Rueffer U; Koch T; Naumann R; Boissevain F; Koch P; Worst P; Soekler M; Eich H; Müller-Hermelink HK; Franklin J; Paulus U; Wolf J; Engert A; Diehl V;
J Clin Oncol; 2003 May; 21(9):1734-9. PubMed ID: 12721249
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapy with etoposide, vincristine, doxorubicin, bolus cyclophosphamide, and oral prednisone in patients with refractory cutaneous T-cell lymphoma.
Akpek G; Koh HK; Bogen S; O'Hara C; Foss FM
Cancer; 1999 Oct; 86(7):1368-76. PubMed ID: 10506727
[TBL] [Abstract][Full Text] [Related]
18. Prospective analysis of treatment outcome and prognostic factors in patients with T-cell lymphomas treated by CEOP-B: single institutional study.
Sung HJ; Kim SJ; Seo HY; Sul HR; Choi JG; Choi IK; Park KH; Oh SC; Seo JH; Choi CW; Kim BS; Shin SW; Kim YH; Kim JS
Br J Haematol; 2006 Jul; 134(1):45-53. PubMed ID: 16803566
[TBL] [Abstract][Full Text] [Related]
19. Hepatosplenic B-cell lymphoma associated with hemophagocytic syndrome: a case report.
Kwon SY; Lee JJ; Chung IJ; Kim HJ; Park MR; Kim HS; Park CS
J Korean Med Sci; 1999 Dec; 14(6):671-4. PubMed ID: 10642947
[TBL] [Abstract][Full Text] [Related]
20. Effects of recombinant granulocyte colony-stimulating factor (G-CSF) in patients treated with ProMACE-CytaBOM for HIV-related non-Hodgkin's lymphoma (NHL).
Rossi G; Donisi A; Casari S; Re A; Stellini R; Cadeo G; Carosi G
Haematologica; 1998 Apr; 83(4):317-22. PubMed ID: 9592981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
